Michael Pietrack sits down with Mark Frohlich, a Harvard-trained medical Oncologist and CEO of Indapta Therapeutics! He discusses his experience in the Pharmaceutical industry as a pioneer in Immuno-Oncology. He emphasizes the importance of understanding the immune system and the integration of different approaches, including the role of artificial intelligence.
Regarding leadership, Frohlich highlights the importance of focusing on tasks that only the leader can do, giving honest feedback, and seeking out mentors for career development.
Key Points:
👨⚕️ Understanding the immune system is crucial in developing effective immunotherapies.
🔜The future of immunotherapy lies in integrating different approaches and leveraging artificial intelligence.
✋As a CEO, focus on tasks that only you can do and delegate other responsibilities.
🔰The "Kind Truth" help employees perform at their best.
📚Seek out mentors for guidance and career development.
Guillaume Beinse, MD, Virgile Tellier, Valentin Charvet, MSc, Eric Deutsch, MD, PhD, Isabelle Borget, PharmD, PhD, Christophe Massard, MD, PhD., Antoine Hollebecque, MD, PhD, and Loic Verlingue, MD
Laleh Amiri-Kordestani & Richard Pazdur
Massimo Di Maio, Francesco Perrone, Pierfranco Conte
Thakur, Sayanta & Lahiry, Sandeep
Jaques van Heerden, MD, Mohamed Zaghloul, MD, Anouk Neven, MSc, Teresa de Rojas, MD, PhD, Jennifer Geel, MD, Catherine Patte, MD, Joyce Balagadde-Kambugu, MD, Peter Hesseling, MD, Francine Tchintseme, MD, Eric Bouffet, MD, and Laila Hessissen, MD
The Oncology Nursing Podcast